Front Row Advisors’s Exponent EXPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-64
Closed -$6.09K 621
2024
Q2
$6.09K Sell
64
-11
-15% -$992 ﹤0.01% 691
2024
Q1
$6.2K Buy
+75
New +$6.2K ﹤0.01% 690
2023
Q4
Sell
-64
Closed -$5.48K 589
2023
Q3
$5.48K Hold
64
﹤0.01% 651
2023
Q2
$6K Hold
64
﹤0.01% 629
2023
Q1
$6K Buy
64
+11
+21% +$1.12K ﹤0.01% 633
2022
Q4
$5K Hold
53
﹤0.01% 633
2022
Q3
$5K Sell
53
-2
-4% -$190 ﹤0.01% 647
2022
Q2
$5K Buy
55
+6
+12% +$565 ﹤0.01% 669
2022
Q1
$5K Hold
49
﹤0.01% 715
2021
Q4
$6K Sell
49
-14
-22% -$1.65K ﹤0.01% 695
2021
Q3
$7K Hold
63
﹤0.01% 652
2021
Q2
$7K Hold
63
﹤0.01% 649
2021
Q1
$6K Sell
63
-33
-34% -$3.1K ﹤0.01% 675
2020
Q4
$9K Hold
96
﹤0.01% 537
2020
Q3
$8K Sell
96
-17
-15% -$1.35K ﹤0.01% 559
2020
Q2
$9K Hold
113
0.01% 491
2020
Q1
$8K Sell
113
-26
-19% -$1.89K 0.01% 509
2019
Q4
$10K Hold
139
0.01% 451
2019
Q3
$10K Buy
139
+15
+12% +$1.01K 0.01% 440
2019
Q2
$7K Hold
124
0.01% 503
2019
Q1
$7K Hold
124
0.01% 505
2018
Q4
$6K Sell
124
-44
-26% -$2.21K 0.01% 495
2018
Q3
$8 Hold
168
0.01% 454
2018
Q2
$8 Hold
168
0.01% 485
2018
Q1
$7K Buy
+168
New +$6.35K ﹤0.01% 492

Other funds holding EXPO

Front Row Advisors's EXPO Position: Q3 2024 in Review

Front Row Advisors sold out of Exponent (EXPO) in Q3 2024, closing a stake of 64 shares — an estimated $6.09K sold.

Front Row Advisors first reported a position in EXPO in Q1 2018 and held it in 25 quarters. The position peaked at $10K in Q4 2019. 373 funds tracked by Wall St. Rank hold EXPO as of Q3 2024.

  • Front Row Advisors reported no remaining Exponent position as of Q3 2024 after selling out during the quarter.
  • Front Row Advisors sold 64 Exponent shares in Q3 2024, an estimated $6.09K.
  • Front Row Advisors first reported a position in Exponent in Q1 2018 and held it in 25 quarters.
  • Front Row Advisors's Exponent position peaked at $10K in Q4 2019.
  • 373 funds tracked by Wall St. Rank held Exponent as of Q3 2024.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.